...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: A couple Q2 events for Zenith
1
May 09, 2017 08:11PM
2
May 10, 2017 10:40AM

BDAZ - Just from keeping my ear to the ground. Heard this from a couple of unrelated people.

tada

1
May 10, 2017 12:54PM
Share
New Message
Please login to post a reply